These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2506804)

  • 21. Binding parameters and microbiological activity of macrolides, lincosamides and streptogramins against Staphylococcus aureus.
    Fournet MP; Barre J; Zini R; Deforges L; Duval J; Tillement JP
    J Pharm Pharmacol; 1987 Apr; 39(4):319-22. PubMed ID: 2884302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA sequence and regulation of ermD, a macrolide-lincosamide-streptogramin B resistance element from Bacillus licheniformis.
    Gryczan T; Israeli-Reches M; Del Bue M; Dubnau D
    Mol Gen Genet; 1984; 194(3):349-56. PubMed ID: 6429477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the macrolide-lincosamide-streptogramin-B-resistance methylase gene, ermE, from Streptomyces erythraeus in Escherichia coli results in N6-monomethylation and N6,N6-dimethylation of ribosomal RNA.
    Katz L; Brown D; Boris K; Tuan J
    Gene; 1987; 55(2-3):319-25. PubMed ID: 3117622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species.
    Reig M; Campello MG; Baquero F
    Antimicrob Agents Chemother; 1987 Apr; 31(4):665-6. PubMed ID: 3111358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanism of macrolide resistance in Streptococcus pneumoniae.
    Shortridge VD; Flamm RK; Ramer N; Beyer J; Tanaka SK
    Diagn Microbiol Infect Dis; 1996 Oct; 26(2):73-8. PubMed ID: 8985659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome.
    Tenson T; Lovmar M; Ehrenberg M
    J Mol Biol; 2003 Jul; 330(5):1005-14. PubMed ID: 12860123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability and expression of the staphylococcal constitutive macrolide-lincosamide-streptogramin B resistance plasmid pE3692 in Staphylococcus aureus and Bacillus subtilis.
    Wieckiewicz J; Wójcik K
    J Basic Microbiol; 1989; 29(2):93-8. PubMed ID: 2496222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labile 50S ribosome from partial macrolide-resistant Staphylococcus aureus.
    Endou K; Endoh S; Matsuoka M; Nakajima Y
    Biol Pharm Bull; 1993 Mar; 16(3):328-30. PubMed ID: 8364485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary relationships of the Bacillus licheniformis macrolide-lincosamide-streptogramin B resistance elements.
    Israeli-Reches M; Weinrauch Y; Dubnau D
    Mol Gen Genet; 1984; 194(3):362-7. PubMed ID: 6429478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a plasmid-specified ribosome methylase associated with macrolide resistance.
    Shivakumar AG; Dubnau D
    Nucleic Acids Res; 1981 Jun; 9(11):2549-62. PubMed ID: 6792593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.
    Matsuoka M; Endou K; Kobayashi H; Inoue M; Nakajima Y
    FEMS Microbiol Lett; 1997 Mar; 148(1):91-6. PubMed ID: 9066116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
    Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L
    Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
    Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
    Lucier TS; Heitzman K; Liu SK; Hu PC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2770-3. PubMed ID: 8593017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator.
    Catchpole I; Dyke KG
    FEMS Microbiol Lett; 1990 May; 57(1-2):43-7. PubMed ID: 2116351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.
    Burridge R; Warren C; Phillips I
    J Antimicrob Chemother; 1986 Mar; 17(3):315-21. PubMed ID: 3084440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial ribosomal subunit synthesis: a novel antibiotic target.
    Champney WS
    Curr Drug Targets Infect Disord; 2001 May; 1(1):19-36. PubMed ID: 12455231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.